|
시장보고서
상품코드
1672958
통풍 치료 시장 : 약제 클래스별, 질환 유형별, 유통 채널별, 투여 경로별, 지역별Gout Disease Treatment Market, By Drug Class, By Disease Type, By Distribution Channel, By Route Of administration, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
세계 통풍 치료 시장은 2025년 30억 4,000만 달러, 2032년에는 53억 2,000만 달러에 달할 것으로 예측되며, 2025-2032년간 연평균 8.3% 성장할 것으로 예상됩니다.
| 보고 범위 | 보고서 상세 내용 | ||
|---|---|---|---|
| 기준 연도 | 2024년 | 2025년 시장 규모 | 30억 4,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2025-2032년 |
| 예측 기간(2025-2032년) CAGR | 8.30% | 2032년 금액 예측 | 53억 2,000만 달러 |
그림. 통풍 치료 시장 점유율(%), 2025년 지역별 시장 점유율
통풍은 일반적인 염증성 관절염의 일종으로 요산 결정이 관절(주로 엄지발가락)에 축적되어 발생하는 질환입니다. 통풍은 하나 이상의 관절에 통증, 부종, 압통을 동반한 갑작스럽고 격렬한 발작을 일으킵니다. 선진국의 알코올 소비 증가, 비만율 증가, 고령화 등이 통풍 유병률 증가에 기여하고 있습니다. 통풍 치료 시장은 통풍 재발을 예방하기 위한 요산 수치 조절에 대한 인식이 높아짐에 따라 더 많은 치료 옵션이 제공됨에 따라 성장할 가능성이 있습니다.
시장 역학
세계 통풍 치료 시장의 성장은 통풍에 취약한 노인 인구 증가, 통풍 위험 증가로 이어지는 비만율 증가, 알코올과 퓨린이 많이 함유된 식품의 소비 증가에 의해 주도되고 있습니다. 또한, 관절 손상을 예방하기 위한 통풍의 조기 진단 및 치료에 대한 인식 증가, 신흥국 시장의 1인당 의료비 증가, 신제품 승인 등이 시장 성장의 원동력이 되고 있습니다. 그러나 알로퓨리놀의 제네릭 경쟁, 약물의 부작용, 환자의 복약 순응도가 시장 성장을 저해하는 요인으로 작용할 수 있습니다. 새로운 치료 대상과 안전성 프로파일을 개선한 파이프라인 의약품의 개발은 시장 진출기업에게 유리한 기회를 제공할 수 있습니다.
본 조사의 주요 특징
- 세계의 통풍 치료 시장에 대해 조사 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 동안 시장 규모(10억 달러)와 연평균 성장률(CAGR)을 조사하여 전해드립니다.
- 또한, 다양한 부문에 걸친 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
- 본 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 통풍 치료 시장의 주요 기업 프로파일을 제공합니다.
- 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 세계 통풍 치료 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 통풍 치료 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.
목차
제1장 조사 목적과 전제조건
- 조사 목적
- 전제조건
- 약어
제2장 시장 전망
- 보고서 설명
- 시장 정의와 범위
- 주요 요약
- Coherent Opportunity Map (COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 성장 촉진요인
- 성장 억제요인
- 기회
- 영향 분석
- 시장 동향
- 규제 시나리오
- 인수와 제휴 시나리오
- 자금조달과 투자
- PEST 분석
- Porter의 Five Forces 분석
제4장 세계의 통풍 치료 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향
- 전체적인 영향
- 정부 이니셔티브
- 시장에 대한 COVID-19의 영향
제5장 세계의 통풍 치료 시장, 약제 클래스별, 2020-2032년(10억 달러)
- 서론
- NSAIDs
- 코르티코스테로이드
- 콜히친
- 요산 저하제
- 기타
제6장 세계의 통풍 치료 시장, 질환 유형별, 2020-2032년(10억 달러)
- 서론
- 급성 통풍
- 만성 통풍
제7장 세계의 통풍 치료 시장, 유통 채널별, 2020-2032년(10억 달러)
- 서론
- 병원 약국
- 소매 약국
- 전문 약국
제8장 세계의 통풍 치료 시장, 투여 경로별, 2020-2032년(10억 달러)
- 서론
- 경구
- 비경구
제9장 세계의 통풍 치료 시장, 지역별, 2020-2032년(10억 달러)
- 서론
- 북미
- 라틴아메리카
- 유럽
- 아시아태평양
- 중동
- 아프리카
제10장 경쟁 구도
- 기업 개요
- Takeda Pharmaceutical Company Ltd.
- Novartis AG
- Regeneron Pharmaceuticals Inc.
- AstraZeneca plc
- Horizon Therapeutics plc
- Merck &Co. Inc.
- Teijin Pharma Ltd.
- GlaxoSmithKline, Plc.
- Zydus Group
- Menarini Group
- JW Pharmaceutical
- Simcere Pharmaceutical Group
- Ionis Pharmaceuticals, Inc.
- Selecta Biosciences
- Mylan NV
제11장 애널리스트 추천 사항
- 융성과 쇠퇴
- Coherent Opportunity Map
제12장 참고 문헌과 조사 방법
- 참고 문헌
- 조사 방법
Global Gout Disease Treatment Market is estimated to be valued at USD 3.04 Bn in 2025 and is expected to reach USD 5.32 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.3% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 3.04 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 8.30% | 2032 Value Projection: | USD 5.32 Bn |
Figure. Gout Disease Treatment Market Share (%), By Region 2025
Gout disease is a common form of inflammatory arthritis that occurs when uric acid crystals accumulate in the joints, typically in the big toe. It causes sudden and severe attacks of pain, swelling and tenderness in one or more joints. Rising consumption of alcohol, obesity rates and aging populations in developed nations have contributed to increase in gout prevalence globally. Global gout disease treatment market can witness growth as more treatment options become available and awareness increases about managing uric acid levels to prevent gout flares.
Market Dynamics:
Global gout disease treatment market growth is driven by growing geriatric population globally who are more prone to develop gout, rising obesity rates leading to higher risk of gout, increasing consumption of alcohol and purine-rich foods. Moreover, growing awareness about early diagnosis and treatment of gout to prevent joint damage, rising per capita healthcare expenditure in developing countries and new product approvals can drive the market growth. However, generic competition for allopurinol, side effects of drugs and patient non-adherence can hamper the market growth. The development of novel treatment targets and pipeline drugs with improved safety profiles can provide lucrative opportunities for market players.
Key Features of the Study:
- This report provides in-depth analysis of the global gout disease treatment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global gout disease treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Takeda Pharmaceutical, Novartis, AstraZeneca, Teijin Pharma, Mylan, and Horizon Therapeutics
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global gout disease treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global gout disease treatment market
Detailed Segmentation-
- By Drug Class
- NSAIDs
- Corticosteroids
- Colchicine
- Urate-Lowering Agents
- Others
- By Disease Type
- Acute Gout
- Chronic Gout
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Specialty Pharmacies
- By Route Of administration
- Oral
- Parentral
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Takeda Pharmaceutical Company Ltd.
- Novartis AG
- Regeneron Pharmaceuticals Inc.
- AstraZeneca plc
- Horizon Therapeutics plc
- Merck & Co. Inc.
- Teijin Pharma Ltd.
- GlaxoSmithKline, Plc.
- Zydus Group
- Menarini Group
- JW Pharmaceutical
- Simcere Pharmaceutical Group
- Ionis Pharmaceuticals, Inc.
- Selecta Biosciences
- Mylan N.V.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Disease Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Route of Administration
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Gout Disease Treatment Market- Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Gout Disease Treatment Market, By Drug Class, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- NSAIDs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Corticosteroids
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Colchicine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Urate-Lowering Agents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Gout Disease Treatment Market, By Disease Type, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Acute Gout
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Chronic Gout
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Gout Disease Treatment Market, By Distribution Channel, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Specialty Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Gout Disease Treatment Market, By Route Of administration, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Parenteral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Gout Disease Treatment Market, By Region, 2020 - 2032, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USDBn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- Takeda Pharmaceutical Company Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Regeneron Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AstraZeneca plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Horizon Therapeutics plc
- Merck & Co. Inc.
- Teijin Pharma Ltd.
- GlaxoSmithKline, Plc.
- Zydus Group
- Menarini Group
- JW Pharmaceutical
- Simcere Pharmaceutical Group
- Ionis Pharmaceuticals, Inc.
- Selecta Biosciences
- Mylan N.V.
- Takeda Pharmaceutical Company Ltd.
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About Us and Sales Contact
